Year archive

BioInvent International — 2013 filings

All 54 regulatory filings released by BioInvent International (BINV) in 2013, sourced directly from the official regulator.

54 Filings

2013 Period

2013 filings (54)

Filing	Released	Lang
BioInvent beviljas patent i USA för antikroppsteknologin F.I.R.S.T.™ Regulatory Filings	2013-11-11	Swedish
BioInvent granted US patent for the F.I.R.S.T.™ antibody screening technology Regulatory Filings	2013-11-11	English
Interim / Quarterly Report 2013 Interim / Quarterly Report 9M 2013	2013-10-24	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report 9M 2013	2013-10-24	English
BioInvent och Bayer förlänger och utvidgar samarbetet för utveckling av terapeutiska antikroppar Regulatory Filings	2013-10-14	Swedish
BioInvent and Bayer extend and broaden collaboration for the discovery and development of therapeutic antibodies Capital/Financing Update	2013-10-14	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-09-12	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-09-02	English
Ändring av antalet aktier och röster i BioInvent International AB (publ) Declaration of Voting Results & Voting Rights Announcements	2013-08-30	Swedish
New number of shares and votes in BioInvent International AB (publ) Declaration of Voting Results & Voting Rights Announcements	2013-08-30	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-08-13	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-07-30	English
Interim / Quarterly Report 2013 Interim / Quarterly Report H1 2013	2013-07-25	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report H1 2013	2013-07-25	English
BioInvent’s rights issue oversubscribed Share Issue/Capital Change	2013-07-25	English
BioInvents nyemission övertecknad Share Issue/Capital Change	2013-07-25	Swedish
BioInvent receives clinical milestone in partner program Regulatory Filings	2013-07-08	English
BioInvent erhåller klinisk milstolpsersättning i partnerprogram Regulatory Filings	2013-07-08	Swedish
BioInvent offentliggör prospekt för företrädesemissionen Report Publication Announcement	2013-07-03	Swedish
BioInvent makes prospectus regarding rights issue public Report Publication Announcement	2013-07-03	English
BioInvent förlänger samarbetet med Mitsubishi Tanabe för utveckling av terapeutiska antikroppar Capital/Financing Update	2013-07-02	Swedish
BioInvent extends collaboration for the discovery and development of therapeutic antibodies with Mitsubishi Tanabe Regulatory Filings	2013-07-02	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-07-01	English
Resolutions at BioInvent’s Extraordinary General Meeting AGM Information	2013-06-19	English
Beslut vid BioInvents extra bolagsstämma AGM Information	2013-06-19	Swedish
BioInvent recruits Michael Oredsson as new CEO Board/Management Information	2013-05-24	English
BioInvent rekryterar Michael Oredsson som ny VD Board/Management Information	2013-05-24	Swedish
Kallelse till extrastämma i BioInvent International AB AGM Information	2013-05-17	Swedish
Major Shareholding Notification 2013 Major Shareholding Notification	2013-04-29	English
Declaration of Voting Results & Voting Rights Announcements 2013 Declaration of Voting Results & Voting Rights Announcements	2013-04-26	English
BioInvent International AB Annual General Meeting AGM Information	2013-04-25	English
Årsstämma i BioInvent International AB AGM Information	2013-04-25	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report Q1 2013	2013-04-25	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report Q1 2013	2013-04-25	English
BioInvent inleder klinisk studie av läkemedelskandidaten BI-505 i patienter med asymptomatiskt multipelt myelom Regulatory Filings	2013-04-22	Swedish
BioInvent initiates clinical trial with BI-505 in smoldering myeloma Regulatory Filings	2013-04-22	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-04-16	English
Prekliniska data publicerade i Cancer Cell framhåller BI-505 och visar på kraftfulla anti-myelom effekter Regulatory Filings	2013-04-16	Swedish
Preclinical data published in Cancer Cell highlight novel antibody BI-505 and potent anti-myeloma activity Regulatory Filings	2013-04-16	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-04-12	English
BioInvent presenterar positiva data för läkemedelskandidaten BI-505 vid internationellt möte om multipelt myelom Regulatory Filings	2013-04-04	Swedish
BioInvent Presents Positive Data for BI-505 at International Myeloma Congress Regulatory Filings	2013-04-04	English
Annual Report 2012 Annual Report FY 2012	2013-03-27	Swedish
Annual Report 2012 Annual Report FY 2012	2013-03-27	English
Notice to attend the Annual General Meeting in BioInvent including a proposal for reduction of the share capital AGM Information	2013-03-26	English
Kallelse till årsstämma i BioInvent innefattande förslag till minskning av aktiekapitalet AGM Information	2013-03-26	Swedish
New Paper in Cell highlights the potential role of TB-403 (anti-PlGF) in the treatment of medulloblastoma, a pediatric brain tumor Regulatory Filings	2013-02-28	English
Ny artikel i Cell visar en potentiell roll för TB-403 (anti-PlGF) vid behandling av medulloblastom, en hjärntumör hos barn Regulatory Filings	2013-02-28	Swedish
Earnings Release 2012 Earnings Release FY 2012	2013-02-21	Swedish
Interim / Quarterly Report 2012 Interim / Quarterly Report FY 2012	2013-02-21	English
Positive results from the BI-505 phase I study in multiple myeloma Earnings Release FY 2013	2013-01-24	English
Positiva resultat i fas I-studien med BI-505 mot multipelt myelom Earnings Release FY 2013	2013-01-24	Swedish
BioInvent recruits new chief executive officer Board/Management Information	2013-01-09	English
BioInvent rekryterar ny verkställande direktör Board/Management Information	2013-01-09	Swedish

Filings by year

2026 11 filings
2025 39 filings
2024 23 filings
2023 29 filings
2022 31 filings
2021 49 filings
2020 55 filings
2019 45 filings
2018 43 filings
2017 28 filings
2016 60 filings
2015 51 filings
2014 40 filings
2013 54 filings
2012 36 filings
2011 23 filings
2010 24 filings
2009 19 filings
2008 12 filings
2007 5 filings